Evidence map›Paper›PMID 25355021›Full record

ArticleOncology nursing forum2014

Perspectives of postmenopausal breast cancer survivors on adjuvant endocrine therapy-related symptoms.

G J van Londen, Heidi S Donovan, Ellen B Beckjord, Alexandra L Cardy, Dana H Bovbjerg, Nancy E Davidson, Jennifer Q Morse, Galen E Switzer, Irma M Verdonck-de Leeuw, Mary Amanda Dew

Abstract read
In one paragraph

Article in Oncology nursing forum, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Provider perspectives on barriers and facilitators to adjuvant endocrine therapy-related symptom management.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2017
    Article
  18. Provider perspectives on patient-provider communication for adjuvant endocrine therapy symptom management.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2017
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

G J van LondenDivision of Hematology-Oncology and Geriatric Medicine in the Department of Medicine, University of Pittsburgh.
Heidi S DonovanDepartment of Acute and Tertiary Care, Office of Community Partnerships, University of Pittsburgh.
Ellen B BeckjordDepartment of Psychiatry, University of Pittsburgh.
Alexandra L CardyBiobehavioral Oncology Program, University of Pittsburgh Cancer Institute.
Dana H BovbjergDepartment of Psychiatry, Psychology, Clinical and Translational Science Institute, Behavioral and Community Health Services, University of Pittsburgh.
Nancy E DavidsonUniversity of Pittsburgh Cancer Institute and UPMC.
Jennifer Q MorseSchool of Health Sciences, Chatham University in Pittsburgh.
Galen E SwitzerDepartment of Medicine, Psychiatry, and Clinical and Translational Science, University of Pittsburgh.
Irma M Verdonck-de LeeuwDepartment of Clinical Psychology, Vrije Universiteit (VU) Medical Center, Amsterdam, Netherlands.
Mary Amanda DewDepartment of Psychiatry, Psychology, Epidemiology, and Biostatistics, University of Pittsburgh.

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Jessie Nedrow · 1988 to 2026
$158.0M
VARIABILITY, STABILITY & SMOOTHNESS OF WALKINGP30AG024827 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JENNIFER S BRACH · 2004 to 2026
$28.6M
University of Pittsburgh Clinical and Translational Science InstitutionKL2TR000146 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2012 to 2015
$8.7M
NCATS NIH HHS KL2 TR000146NCI NIH HHS CA047904NCI NIH HHS P30 CA047904NIA NIH HHS AG024827NIA NIH HHS P30 AG024827
6 · The paper itself

Abstract

PURPOSE/

objectivesTo conduct an investigation of women's experiences related to adjuvant endocrine therapy (AET) and managing AET-related symptoms. RESEARCH APPROACH: Qualitative, focus group design.

settingMain campus of the University of Pittsburgh in Pennsylvania.

participants14 breast cancer survivors, aged 50 years or older, with AET-related symptoms. METHODOLOGIC APPROACH: Semistructured discussion guides were used to elicit recollections of conversations with healthcare providers about starting AET, symptom experiences, symptom management, and suggestions for improving management. Audiotaped discussions were transcribed and analyzed to identify themes.

findingsWomen reported that, initially, AET was not viewed as a choice, but rather as the necessary next step to save their lives. After starting AET, women experienced difficulties making sense of, communicating about, and managing unanticipated AET-related symptoms. Women who experienced persistently bothersome symptoms began weighing the pros and cons of AET to decide whether to continue treatment.

conclusionsFocus group findings suggest multiple opportunities to better prepare patients for AET and to improve assessment and management of AET-related symptoms.

interpretationBy exploring AET-related symptom experiences, nurses may be able to promote AET adherence in breast cancer survivors.

Indexed as

Attitude to HealthBreast NeoplasmsPostmenopauseSurvivorsChemotherapy, AdjuvantEstrogen AntagonistsFemaleFocus GroupsHumansMiddle AgedTamoxifenEstrogen AntagonistsTamoxifenadjuvant endocrine therapybreast cancerquality of life

Identifiers

PMID25355021
PMCPMC4500054

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.